Literature DB >> 19122201

The eighth fibronectin type III domain of protein tyrosine phosphatase receptor J influences the formation of protein complexes and cell localization.

Rodolfo Iuliano1, Cinzia Raso, Alfina Quintiero, Ilaria Le Pera, Flavia Pichiorri, Tiziana Palumbo, Dario Palmieri, Alessandra Pattarozzi, Tullio Florio, Giuseppe Viglietto, Francesco Trapasso, Carlo Maria Croce, Alfredo Fusco.   

Abstract

Regulation of receptor-type phosphatases can involve the formation of higher-order structures, but the exact role played in this process by protein domains is not well understood. In this study we show the formation of different higher-order structures of the receptor-type phosphatase PTPRJ, detected in HEK293A cells transfected with different PTPRJ expression constructs. In the plasma membrane PTPRJ forms dimers detectable by treatment with the cross-linking reagent BS(3) (bis[sulfosuccinimidyl]suberate). However, other PTPRJ complexes, dependent on the formation of disulfide bonds, are detected by treatment with the oxidant agent H(2)O(2) or by a mutation Asp872Cys, located in the eighth fibronectin type III domain of PTPRJ. A deletion in the eighth fibronectin domain of PTPRJ impairs its dimerization in the plasma membrane and increases the formation of PTPRJ complexes dependent on disulfide bonds that remain trapped in the cytoplasm. The deletion mutant maintains the catalytic activity but is unable to carry out inhibition of proliferation on HeLa cells, achieved by the wild type form, since it does not reach the plasma membrane. Therefore, the intact structure of the eighth fibronectin domain of PTPRJ is critical for its localization in plasma membrane and biological function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19122201     DOI: 10.1093/jb/mvn175

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  6 in total

1.  Receptor type protein tyrosine phosphatases (RPTPs) - roles in signal transduction and human disease.

Authors:  Yiru Xu; Gary J Fisher
Journal:  J Cell Commun Signal       Date:  2012-08-01       Impact factor: 5.782

2.  Role of PTPRJ genotype in papillary thyroid carcinoma risk.

Authors:  Rodolfo Iuliano; Dario Palmieri; Huiling He; Angela Iervolino; Eleonora Borbone; Pierlorenzo Pallante; Alessandra Cianflone; Rebecca Nagy; Hansjuerg Alder; George A Calin; Francesco Trapasso; Carla Giordano; Carlo M Croce; Albert de la Chapelle; Alfredo Fusco
Journal:  Endocr Relat Cancer       Date:  2010-10-29       Impact factor: 5.678

3.  Mutations in PTPRQ are a cause of autosomal-recessive nonsyndromic hearing impairment DFNB84 and associated with vestibular dysfunction.

Authors:  Margit Schraders; Jaap Oostrik; Patrick L M Huygen; Tim M Strom; Erwin van Wijk; Henricus P M Kunst; Lies H Hoefsloot; Cor W R J Cremers; Ronald J C Admiraal; Hannie Kremer
Journal:  Am J Hum Genet       Date:  2010-03-25       Impact factor: 11.025

4.  Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors.

Authors:  Chanel E Smart; Marjan E Askarian Amiri; Ania Wronski; Marcel E Dinger; Joanna Crawford; Dmitry A Ovchinnikov; Ana Cristina Vargas; Lynne Reid; Peter T Simpson; Sarah Song; Christiane Wiesner; Juliet D French; Richa K Dave; Leonard da Silva; Amy Purdon; Megan Andrew; John S Mattick; Sunil R Lakhani; Melissa A Brown; Stuart Kellie
Journal:  PLoS One       Date:  2012-07-17       Impact factor: 3.240

5.  A novel splice variant of the protein tyrosine phosphatase PTPRJ that encodes for a soluble protein involved in angiogenesis.

Authors:  Anna Bilotta; Vincenzo Dattilo; Sabrina D'Agostino; Stefania Belviso; Stefania Scalise; Mariaconcetta Bilotta; Eugenio Gaudio; Francesco Paduano; Nicola Perrotti; Tullio Florio; Alfredo Fusco; Rodolfo Iuliano; Francesco Trapasso
Journal:  Oncotarget       Date:  2017-02-07

6.  Disrupting the transmembrane domain-mediated oligomerization of protein tyrosine phosphatase receptor J inhibits EGFR-driven cancer cell phenotypes.

Authors:  Elizabeth Bloch; Eden L Sikorski; David Pontoriero; Evan K Day; Bryan W Berger; Matthew J Lazzara; Damien Thévenin
Journal:  J Biol Chem       Date:  2019-11-01       Impact factor: 5.486

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.